NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP)
CUSIP: 44975P103
Q2 2020 13F Holders as of 30 Jun 2020
- Type / Class
- Equity / Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares)
- Shares outstanding
- 265,214,861
- Total 13F shares
- 3,298,968
- Share change
- -140,700
- Total reported value
- $97,724,000
- Price per share
- $29.93
- Number of holders
- 19
- Value change
- -$2,617,263
- Number of buys
- 12
- Number of sells
- 10
Quarterly Holders Quick Answers
What is CUSIP 44975P103?
CUSIP 44975P103 identifies NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 44975P103:
Top shareholders of NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.38%
|
1,000,000
|
$13,000,000 | — | 31 Mar 2020 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.31%
|
830,326
|
$10,794,000 | — | 31 Mar 2020 | |
| Sio Capital Management, LLC |
13F
|
Company |
0.18%
|
472,675
|
$6,145,000 | — | 31 Mar 2020 | |
| Artisan Partners Limited Partnership |
13F
|
Company |
0.15%
|
407,248
|
$5,294,000 | — | 31 Mar 2020 | |
| Artal Group S.A. |
13F
|
Company |
0.13%
|
350,000
|
$4,550,000 | — | 31 Mar 2020 | |
| MORGAN STANLEY |
13F
|
Company |
0.07%
|
175,000
|
$2,275,000 | — | 31 Mar 2020 | |
| NS Partners Ltd |
13F
|
Company |
0.02%
|
54,800
|
$712,000 | — | 31 Mar 2020 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.01%
|
34,966
|
$455,000 | — | 31 Mar 2020 | |
| NORGES BANK |
13F
|
Company |
0.01%
|
30,000
|
$390,000 | — | 31 Mar 2020 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.01%
|
26,409
|
$343,000 | — | 31 Mar 2020 | |
| Vident Investment Advisory, LLC |
13F
|
Company |
0.01%
|
19,822
|
$258,000 | — | 31 Mar 2020 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.01%
|
18,735
|
$244,000 | — | 31 Mar 2020 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.01%
|
17,193
|
$224,000 | — | 31 Mar 2020 | |
| UBS Group AG |
13F
|
Company |
0%
|
1,985
|
$26,000 | — | 31 Mar 2020 | |
| Snow Lake Capital (HK) Ltd |
13F
|
Company |
0.47%
|
1,240,700
|
$16,129 | — | 31 Mar 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0%
|
509
|
$7,000 | — | 31 Mar 2020 |
Institutional Holders of NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) as of Q2 2020
As of 30 Jun 2020,
NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) was held by
19 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,298,968 shares.
The largest 10 holders included
ADAGE CAPITAL PARTNERS GP, L.L.C., MANUFACTURERS LIFE INSURANCE COMPANY, THE, Artisan Partners Limited Partnership, Artal Group S.A., MORGAN STANLEY, Sio Capital Management, LLC, FMR LLC, FRANKLIN RESOURCES INC, Candriam Luxembourg S.C.A., and NORGES BANK.
This page lists
19
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2020 vs Q1 2020 Across Filers
Q1 2020 holders
15
Q2 2020 holders
19
Holder diff
4
| Investor | Q1 2020 Shares | Q2 2020 Shares | Share Diff | Share Chg % | Q1 2020 Value $ | Q2 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.